XR Securities LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
XR Securities LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$36,000
+12.5%
12,200
-64.8%
0.00%
-50.0%
Q2 2020$32,000
+113.3%
34,700
+191.6%
0.00%
+300.0%
Q1 2020$15,000
+1400.0%
11,900
+15.5%
0.00%
Q4 2019$1,000
-75.0%
10,300
-9.6%
0.00%
-100.0%
Q3 2019$4,000
-66.7%
11,400
-2.6%
0.00%
-50.0%
Q2 2019$12,000
-29.4%
11,700
+17.0%
0.00%
-71.4%
Q4 2018$17,000
-70.7%
10,000
-35.9%
0.01%
-53.3%
Q3 2018$58,00015,6000.02%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders